|
Thorvardur (Thor) Ragnar Halfdanarson, M.D. | Neuroendocrine Neoplasms (NENs) - An Ongoing Odyssey in the Land of Small Tumors |
05/27/2021 - 8:00am to 9:00am |
|
Katharine A. Price, M.D. | HPV Vaccination: Can we do better? |
06/03/2021 - 8:00am to 9:00am |
|
Gregory A. Poland, M.D., FIDSA, MACP, FRCP (hon) | COVID-19: Variants and Vaccines |
06/10/2021 - 8:00am to 9:00am |
|
Michael Sughrue, M.D. | Connectomics: Reducing the Cognitive Footprint in Neurosurgery |
06/17/2021 - 8:00am to 9:00am |
|
Jeffrey M. Trent, Ph.D., F.A.C.M.G.G. | Learning Lessons from the Rare: Moving from Integrated “omic” Analysis to Innovative Clinical Trials of Rare Childhood and AYA Cancers |
06/24/2021 - 8:00am to 9:00am |
|
Mitesh J. Borad, M.D. | Precision Medicine in Hepatobiliary Cancers |
07/01/2021 - 8:00am to 9:00am |
|
Craig R. Nichols, M.D., FACP | A medical oncology conservative's viewpoint of the near-future state of germ cell tumor management: Right Patient, Right Time, Right Intervention, and a bit more |
07/08/2021 - 8:00am to 9:00am |
|
Bradford (Brad) S. Hoppe, M.D., M.P.H., Sameer R. Keole, M.D., and Anita Mahajan, M.D.| Particle Therapy Past, Present, Future |
07/22/2021 - 8:00am to 9:00am |
|
Dr. A. Keith Stewart, MBChB, MRCP, FRCPC, MBA | Myeloma from Phase 3 to Phase 0 |
07/29/2021 - 8:00am to 9:00am |
|
Professor Paul A. Harris, PhD, FACMI, FIAHSI | “REDCap for clinical trials: Great capabilities and exciting potential” |
08/05/2021 - 8:00am to 9:00am |